Trial Profile
Evaluation of Efficacy and Safety of Risperidone in Long-acting Microspheres in Patients With Schizophrenia, Schizophreniform or Schizoaffective Disorders Diagnosed According to the DSM-IV Criteria, After Switching Treatment With Any Antipsychotic Therapy With Long-acting Microspheres of Risperidone
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 18 Aug 2013
Price :
$35
*
At a glance
- Drugs Risperidone (Primary)
- Indications Psychotic disorders; Schizoaffective disorder; Schizophrenia
- Focus Therapeutic Use
- 21 May 2013 New trial record